⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CPHI News
China Pharma Holdings, Inc.
China Pharma Holdings, Inc. States It Knows of No Events That Could Have Caused Unusual Market Activity
prnewswire.com
CPHI
China Pharma Holdings, Inc. States It Knows of No Events That Could Have Caused Unusual Market Activity
prnewswire.com
CPHI
CardioPharma Reviews Applications to Explore Non-Cardiovascular Benefits of CVD Polypill
prnewswire.com
CPHI
Santhera Publishes Agenda for its Annual General Meeting
globenewswire.com
CPHI
Ickey Woods Kicks Off "Score 6 for 24" Fundraising Campaign to Expand Asthma Testing for Children Nationwide
prnewswire.com
CPHI
Form 8-K
sec.gov
CPHI
Santhera Licenses AGAMREE® (Vamorolone) to Nxera Pharma in Japan, South Korea, Australia and New Zealand in a Deal Valued at up to USD 205 Million Plus Royalties
globenewswire.com
CPHI
CardioPharma Requests Applications to Investigate the Non-Cardiovascular Benefits of CVD Polypills
prnewswire.com
CPHI